ORTEXORTEX News
Tracking CHH? Get live short interest, options flow, and signals on ORTEX.Sign up free →
CH
Earnings PreviewCHH

Choice Hotels Short Sellers Stay Elevated Ahead of Q3 Print

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 2 Nov 2026, 04:04

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Short sellers have built a substantial position in CHH, with 13.7% of the free float now borrowed against the stock. That figure rose 5.2% over the past week, even as the shares gained 2.5% to close at $111.16 on Friday, lagging a peer median of roughly 4.2%.

The borrow market tells a more relaxed story than the headline short interest figure suggests. Availability has eased considerably from a period of acute tightness: at the start of October, availability dropped to near zero and the cost to borrow spiked to 18.8% on October 1, reflecting a severe squeeze on lending supply. Since then, conditions have loosened sharply. Availability now stands at 144%, meaning there are roughly 1.4 shares available to lend for every share already borrowed. Borrowing costs have fallen to 1.1%, down from those October highs. The ORTEX short score of 78, ranking in the 97th percentile of the broader universe, confirms that short positioning remains elevated relative to peers, but the acute pressure in the lending market has passed.

Options positioning has turned more cautious than usual. The put/call ratio jumped to 1.97, well above its 20-day average of 1.25, driven by a cluster of put demand that arrived around October 19 and has held. While the z-score of 0.96 places this within roughly one standard deviation of normal, the absolute level of the ratio is closer to the top of its 52-week range of 0.27 to 2.66. That shift happened as the stock was recovering, which adds an interesting texture: the rally did not pull defensive options positioning off the table.

The analyst community remains divided, and the division leans bearish. Morgan Stanley, JP Morgan, Barclays, and Wells Fargo have all nudged targets marginally higher in recent weeks while keeping Underweight or Neutral ratings. Morgan Stanley's target of $93 sits 16% below the current price. Truist and Baird hold Buy and Outperform ratings with targets in the $128 to $129 range. The consensus mean target of $114.65 implies only modest upside from current levels, and the weight of recent activity has been incremental target-raising without conviction upgrades. Baron Capital Group stands out on the ownership side, having added 1.6 million shares in the quarter ending September 30, lifting its stake to 20.9% of shares outstanding, a significant accumulation from a single holder.

The CEO sold 1,227 shares at $112 on October 20 under a pre-arranged 10b5-1 plan, a transaction that carries less weight than a discretionary sale but is worth noting given the timing. The net insider position over 90 days is a modest net sale of around $678,000, with the bulk of the other recent filings being small automatic share awards to board members.

The Q3 print will test whether the company's unit economics and revenue-per-available-room trends can justify a stock trading at 14.9 times earnings and near its highest price-to-book multiple in 30 days, against a backdrop where the largest bloc of street opinion remains underweight.

Stocks in this article

See the live data behind this article on ORTEX.

Open CHH on ORTEX →

How this article was generated

Generated
2 Nov 2026, 04:27
Data as of
2 Nov 2026, 04:04
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.